Dashboard
Manage Tickers

MNPRMonopar Therapeutics

Nasdaq monopartx.com


$ 0.65 $ 0.01 (1.54 %)    

Wednesday, 01-May-2024 15:59:48 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 429.07 $ 3.83 (0.9 %)
DIA $ 382.31 $ 3.34 (0.88 %)
SPY $ 505.01 $ 0.61 (0.12 %)
TLT $ 88.87 $ 0.31 (0.35 %)
GLD $ 213.12 $ -0.67 (-0.31 %)
$ 0.66
$ 0.65
$ 0.00 x 0
$ 0.00 x 0
$ 0.65 - $ 0.65
$ 0.27 - $ 1.75
31,435
na
11.52M
$ 0.38
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 03-28-2024 12-31-2023 10-K
2 11-09-2023 09-30-2023 10-Q
3 08-10-2023 06-30-2023 10-Q
4 05-11-2023 03-31-2023 10-Q
5 03-23-2023 12-31-2022 10-K
6 11-10-2022 09-30-2022 10-Q
7 08-11-2022 06-30-2022 10-Q
8 05-12-2022 03-31-2022 10-Q
9 03-24-2022 12-31-2021 10-K
10 11-12-2021 09-30-2021 10-Q
11 08-12-2021 06-30-2021 10-Q
12 05-13-2021 03-31-2021 10-Q
13 03-25-2021 12-31-2020 10-K
14 11-12-2020 09-30-2020 10-Q
15 08-06-2020 06-30-2020 10-Q
16 05-07-2020 03-31-2020 10-Q
17 03-27-2020 12-31-2019 10-K
18 11-12-2019 09-30-2019 10-Q
19 08-08-2019 06-30-2019 10-Q
20 05-10-2019 03-31-2019 10-Q
21 02-26-2019 12-31-2018 10-K
22 11-09-2018 09-30-2018 10-Q
23 08-09-2018 06-30-2018 10-Q
24 05-11-2018 03-31-2018 10-Q
25 03-26-2018 12-31-2017 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

monopar-announces-radiopharma-presentation-selected-for-society-of-nuclear-medicine-and-molecular-imaging-2024-annual-meeting
Monopar Announces Radiopharma Presentation...
04/18/2024 12:13:16

Monopar Therapeutics Inc. (NASDAQ:MNPR), a clinical-stage biopharmaceutical company focused on developing innovative treatments...

monopar-announces-filing-of-patent-protecting-mnpr-101-radiopharma-optimization-findings
Monopar Announces Filing Of Patent Protect...
04/16/2024 12:05:21

Monopar Therapeutics Inc. (NASDAQ:MNPR), a clinical-stage biopharmaceutical company focused on developing innovative treatments...

jonestrading-upgrades-monopar-therapeutics-to-buy-announces-2-price-target
JonesTrading Upgrades Monopar Therapeutics...
04/11/2024 11:39:39

JonesTrading analyst Soumit Roy upgrades Monopar Therapeutics (NASDAQ:MNPR) from Hold to Buy and announces $2 price target.

monopar-initiates-radiopharma-phase-1-clinical-trial-for-mnpr-101-zr-in-advanced-cancer-patients
Monopar Initiates Radiopharma Phase 1 Clin...
04/10/2024 12:02:16

recap-monopar-therapeutics-q4-earnings
Recap: Monopar Therapeutics Q4 Earnings
03/28/2024 11:45:06

monopars-cash-cash-equivalents-and-short-term-investments-as-of-december-31-2023-were-73m-sufficient-to-continue-operations-at-least-through-june-30-2025
Monopar's Cash, Cash Equivalents And Short...
03/28/2024 11:26:36

monopar-therapeutics-q4-gaap-eps-012-beats-015-estimate
Monopar Therapeutics Q4 GAAP EPS $(0.12) B...
03/28/2024 11:26:13

Monopar Therapeutics (NASDAQ:MNPR) reported quarterly losses of $(0.12) per share which beat the analyst consensus estimate of ...

why-peraso-shares-are-trading-lower-by-over-23-here-are-other-stocks-moving-in-tuesdays-mid-day-session
Why Peraso Shares Are Trading Lower By Ove...
03/19/2024 17:48:27

Shares of Peraso Inc. (NASDAQ: PRSO) fell sharply during Tuesday’s session after the company reported worse-than-expected four...

monopar-therapeutics-announced-preclinical-imaging-data-of-a-therapeutic-radioisotope-bound-to-its-proprietary-upar-urokinase-plasminogen-activator-receptor-targeting-agent-mnpr-101-demonstrating-preferential-uptake-in-the-tumor
Monopar Therapeutics Announced Preclinical...
03/05/2024 12:15:08

monopar-therapeutics-says-nasdaq-has-granted-co-180-day-extension-to-aug-26-to-regain-compliance
Monopar Therapeutics Says Nasdaq Has Grant...
02/28/2024 19:04:04

-SEC Filing

monopar-therapeutics-provides-update-on-mnpr-101-zr-radiopharma-clinical-trial-8k
Monopar Therapeutics Provides Update On MN...
02/27/2024 12:13:08

Rradiopharmaceutical physician, Professor Rodney Hicks, will be the lead investigator for Monopar's MNPR-101-Zr Phase 1 dos...

12-health-care-stocks-moving-in-mondays-pre-market-session
12 Health Care Stocks Moving In Monday's P...
02/26/2024 13:06:06

12-health-care-stocks-moving-in-fridays-intraday-session
12 Health Care Stocks Moving In Friday's I...
02/23/2024 17:31:12

crude-oil-down-2-maravai-lifesciences-shares-spike-higher
Crude Oil Down 2%; Maravai LifeSciences Sh...
02/23/2024 17:26:52

U.S. stocks traded mostly higher midway through trading, with the Dow Jones index jumping more than 100 points on Friday. The ...

dow-surges-over-150-points-aercap-posts-upbeat-earnings
Dow Surges Over 150 Points; AerCap Posts U...
02/23/2024 15:25:13

U.S. stocks traded higher this morning, with the Dow Jones index jumping more than 150 points on Friday.

dow-gains-over-400-points-keurig-dr-pepper-shares-fall-after-q4-results
Dow Gains Over 400 Points; Keurig Dr Peppe...
02/22/2024 19:56:29

U.S. stocks traded higher toward the end of trading, with the Dow Jones index jumping more than 400 points on Thursday. The Do...

why-etsy-shares-are-trading-lower-by-around-8-here-are-other-stocks-moving-in-thursdays-mid-day-session
Why Etsy Shares Are Trading Lower By Aroun...
02/22/2024 18:37:58

Shares of Etsy, Inc.

whats-going-on-with-cancer-focused-monopar-therapeutics-stock-today
What's Going On With Cancer-Focused Monopa...
02/22/2024 18:02:47

Monopar Therapeutics soars 36% in premarket trading on robust volume. Exciting preclinical data reveals MNPR-101's potent a...

12-health-care-stocks-moving-in-thursdays-intraday-session
12 Health Care Stocks Moving In Thursday's...
02/22/2024 17:31:10

crude-oil-rises-1-us-jobless-claims-fall-to-201000
Crude Oil Rises 1%; US Jobless Claims Fall...
02/22/2024 17:11:36

U.S. stocks traded higher midway through trading, with the Nasdaq Composite jumping around 300 points on Thursday. The Dow tra...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION